Matthew P Pase1, Alexa Beiser1, Danielle Enserro1, Vanessa Xanthakis1, Hugo Aparicio1, Claudia L Satizabal1, Jayandra J Himali1, Carlos S Kase1, Ramachandran S Vasan1, Charles DeCarli1, Sudha Seshadri2. 1. From the Department of Neurology (M.P.P., A.B., H.A., C.L.S., J.J.H., S.S.), and Section of Preventive Medicine, Department of Medicine (D.E., V.X., R.S.V.), Boston University School of Medicine and Framingham Heart Study (M.P.P., A.B., D.E., V.X., H.A., C.L.S., J.J.H., R.S.V., S.S.), Boston, MA; Centre for Human Psychopharmacology, Swinburne University of Technology, Melbourne, Victoria, Australia (M.P.P.); Department of Biostatistics, Boston University School of Public Health, MA (A.B.); Department of Neurology, Boston Medical Centre, MA (H.A., C.S.K.); and Department of Neurology, School of Medicine and Imaging of Dementia and Aging Laboratory, Center for Neuroscience, University of California Davis, Sacramento (C.D.). 2. From the Department of Neurology (M.P.P., A.B., H.A., C.L.S., J.J.H., S.S.), and Section of Preventive Medicine, Department of Medicine (D.E., V.X., R.S.V.), Boston University School of Medicine and Framingham Heart Study (M.P.P., A.B., D.E., V.X., H.A., C.L.S., J.J.H., R.S.V., S.S.), Boston, MA; Centre for Human Psychopharmacology, Swinburne University of Technology, Melbourne, Victoria, Australia (M.P.P.); Department of Biostatistics, Boston University School of Public Health, MA (A.B.); Department of Neurology, Boston Medical Centre, MA (H.A., C.S.K.); and Department of Neurology, School of Medicine and Imaging of Dementia and Aging Laboratory, Center for Neuroscience, University of California Davis, Sacramento (C.D.). suseshad@bu.edu.
Abstract
BACKGROUND AND PURPOSE: The American Heart Association developed the ideal cardiovascular health (CVH) index as a simple tool to promote CVH; yet, its association with brain atrophy and dementia remains unexamined. METHODS: Our aim was to investigate the prospective association of ideal CVH with vascular brain injury, including the 10-year risks of incident stroke and dementia, as well as cognitive decline and brain atrophy on magnetic resonance imaging, measured for ≈7 years. We studied 2750 stroke- and dementia-free Framingham Heart Study Offspring cohort participants (mean age, 62±9 years; 45% men). Ideal CVH was quantified on a 7-point scale with 1 point awarded for each of the following: nonsmoking status, ideal body mass index, regular physical activity, healthy diet, as well as optimum blood pressure, cholesterol, and fasting blood glucose. Both recent (baseline) and remote (6.9 years earlier) ideal CVH scores were examined. RESULTS: Recent ideal CVH was associated with stroke (hazard ratio, 0.80; 95% confidence interval, 0.67-0.95), vascular dementia (hazard ratio, 0.49; 95% confidence interval, 0.30-0.81), frontal brain atrophy (P=0.003), and cognitive decline on tasks measuring visual memory and reasoning (P<0.05). In addition to predicting stroke, vascular dementia, whole-brain atrophy, and cognitive decline, remote ideal CVH was associated with the incidence of all-cause dementia (hazard ratio, 0.80; 95% confidence interval, 0.67-0.97) and Alzheimer disease (hazard ratio, 0.79; 95% confidence interval, 0.64-0.98). CONCLUSIONS: Adherence to the American Heart Association's ideal CVH factors and behaviors, particularly in midlife, may protect against cerebrovascular disease and dementia.
BACKGROUND AND PURPOSE: The American Heart Association developed the ideal cardiovascular health (CVH) index as a simple tool to promote CVH; yet, its association with brain atrophy and dementia remains unexamined. METHODS: Our aim was to investigate the prospective association of ideal CVH with vascular brain injury, including the 10-year risks of incident stroke and dementia, as well as cognitive decline and brain atrophy on magnetic resonance imaging, measured for ≈7 years. We studied 2750 stroke- and dementia-free Framingham Heart Study Offspring cohort participants (mean age, 62±9 years; 45% men). Ideal CVH was quantified on a 7-point scale with 1 point awarded for each of the following: nonsmoking status, ideal body mass index, regular physical activity, healthy diet, as well as optimum blood pressure, cholesterol, and fasting blood glucose. Both recent (baseline) and remote (6.9 years earlier) ideal CVH scores were examined. RESULTS: Recent ideal CVH was associated with stroke (hazard ratio, 0.80; 95% confidence interval, 0.67-0.95), vascular dementia (hazard ratio, 0.49; 95% confidence interval, 0.30-0.81), frontal brain atrophy (P=0.003), and cognitive decline on tasks measuring visual memory and reasoning (P<0.05). In addition to predicting stroke, vascular dementia, whole-brain atrophy, and cognitive decline, remote ideal CVH was associated with the incidence of all-cause dementia (hazard ratio, 0.80; 95% confidence interval, 0.67-0.97) and Alzheimer disease (hazard ratio, 0.79; 95% confidence interval, 0.64-0.98). CONCLUSIONS: Adherence to the American Heart Association's ideal CVH factors and behaviors, particularly in midlife, may protect against cerebrovascular disease and dementia.
Authors: Ramona O Hopkins; Callie J Beck; David L Burnett; Lindell K Weaver; Jeff Victoroff; Erin D Bigler Journal: J Neuroimaging Date: 2006-07 Impact factor: 2.486
Authors: Charles DeCarli; Joseph Massaro; Danielle Harvey; John Hald; Mats Tullberg; Rhoda Au; Alexa Beiser; Ralph D'Agostino; Philip A Wolf Journal: Neurobiol Aging Date: 2005-04 Impact factor: 4.673
Authors: Vanessa Xanthakis; Danielle M Enserro; Joanne M Murabito; Joseph F Polak; Kai C Wollert; James L Januzzi; Thomas J Wang; Geoffrey Tofler; Ramachandran S Vasan Journal: Circulation Date: 2014-10-01 Impact factor: 29.690
Authors: Stéphanie Debette; Alexa Beiser; Udo Hoffmann; Charles Decarli; Christopher J O'Donnell; Joseph M Massaro; Rhoda Au; Jayandra J Himali; Philip A Wolf; Caroline S Fox; Sudha Seshadri Journal: Ann Neurol Date: 2010-08 Impact factor: 10.422
Authors: Sudha Seshadri; Philip A Wolf; Alexa S Beiser; Jacob Selhub; Rhoda Au; Paul F Jacques; Mitsuhiro Yoshita; Irwin H Rosenberg; Ralph B D'Agostino; Charles DeCarli Journal: Arch Neurol Date: 2008-05
Authors: Matthew P Pase; Jayandra J Himali; Alexa S Beiser; Hugo J Aparicio; Claudia L Satizabal; Ramachandran S Vasan; Sudha Seshadri; Paul F Jacques Journal: Stroke Date: 2017-05 Impact factor: 7.914
Authors: Matthew P Pase; Jayandra J Himali; Paul F Jacques; Charles DeCarli; Claudia L Satizabal; Hugo Aparicio; Ramachandran S Vasan; Alexa S Beiser; Sudha Seshadri Journal: Alzheimers Dement Date: 2017-03-06 Impact factor: 21.566
Authors: Hector M González; Wassim Tarraf; Kimystian Harrison; B Gwen Windham; Jonathan Tingle; Alvaro Alonso; Michael Griswold; Gerardo Heiss; David Knopman; Thomas H Mosley Journal: Alzheimers Dement Date: 2017-12-18 Impact factor: 21.566
Authors: Jaime Perales-Puchalt; Michelle L Vidoni; Juan Llibre Rodríguez; Eric D Vidoni; Sandra Billinger; Jeffrey Burns; Maëlenn Guerchet; MinJae Lee Journal: Int J Geriatr Psychiatry Date: 2019-04-23 Impact factor: 3.485
Authors: Wilby Williamson; Adam J Lewandowski; Nils D Forkert; Ludovica Griffanti; Thomas W Okell; Jill Betts; Henry Boardman; Timo Siepmann; David McKean; Odaro Huckstep; Jane M Francis; Stefan Neubauer; Renzo Phellan; Mark Jenkinson; Aiden Doherty; Helen Dawes; Eleni Frangou; Christina Malamateniou; Charlie Foster; Paul Leeson Journal: JAMA Date: 2018-08-21 Impact factor: 56.272
Authors: Jaime Perales-Puchalt; Kathryn Gauthreaux; Ashley Shaw; Jerrihlyn L McGee; Merilee A Teylan; Kwun C G Chan; Katya Rascovsky; Walter A Kukull; Eric D Vidoni Journal: Int Psychogeriatr Date: 2020-01-17 Impact factor: 3.878
Authors: Justin B Echouffo-Tcheugui; Sarah C Conner; Jayandra J Himali; Pauline Maillard; Charles S DeCarli; Alexa S Beiser; Ramachandran S Vasan; Sudha Seshadri Journal: Neurology Date: 2018-10-24 Impact factor: 9.910